DISHMAN CARBOGEN AMCIS | ZANDU REALTY | DISHMAN CARBOGEN AMCIS/ ZANDU REALTY |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -20.7 | 24.2 | - | View Chart |
P/BV | x | 0.6 | 0.8 | 82.8% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
DISHMAN CARBOGEN AMCIS ZANDU REALTY |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
DISHMAN CARBOGEN AMCIS Mar-24 |
ZANDU REALTY Mar-17 |
DISHMAN CARBOGEN AMCIS/ ZANDU REALTY |
5-Yr Chart Click to enlarge
|
||
High | Rs | 283 | 1,670 | 16.9% | |
Low | Rs | 113 | 1,030 | 11.0% | |
Sales per share (Unadj.) | Rs | 166.8 | 63.3 | 263.6% | |
Earnings per share (Unadj.) | Rs | -9.8 | 63.9 | -15.3% | |
Cash flow per share (Unadj.) | Rs | 10.0 | 63.9 | 15.7% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 358.9 | 2,438.1 | 14.7% | |
Shares outstanding (eoy) | m | 156.78 | 0.81 | 19,355.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.2 | 21.2 | 5.6% | |
Avg P/E ratio | x | -20.2 | 21.0 | -96.3% | |
P/CF ratio (eoy) | x | 19.7 | 21.0 | 93.8% | |
Price / Book Value ratio | x | 0.6 | 0.6 | 100.1% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 31,059 | 1,089 | 2,852.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 12,082 | 3 | 394,823.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 26,158 | 51 | 51,019.5% | |
Other income | Rs m | 508 | 117 | 434.8% | |
Total revenues | Rs m | 26,666 | 168 | 15,863.9% | |
Gross profit | Rs m | 2,578 | -37 | -6,924.0% | |
Depreciation | Rs m | 3,109 | 0 | - | |
Interest | Rs m | 1,200 | 14 | 8,424.9% | |
Profit before tax | Rs m | -1,223 | 65 | -1,870.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 312 | 14 | 2,296.8% | |
Profit after tax | Rs m | -1,535 | 52 | -2,963.5% | |
Gross profit margin | % | 9.9 | -72.6 | -13.6% | |
Effective tax rate | % | -25.5 | 20.8 | -122.8% | |
Net profit margin | % | -5.9 | 101.0 | -5.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 19,282 | 270 | 7,152.3% | |
Current liabilities | Rs m | 25,547 | 118 | 21,670.4% | |
Net working cap to sales | % | -24.0 | 295.9 | -8.1% | |
Current ratio | x | 0.8 | 2.3 | 33.0% | |
Inventory Days | Days | 41 | 12,983 | 0.3% | |
Debtors Days | Days | 6 | 0 | - | |
Net fixed assets | Rs m | 76,424 | 1,824 | 4,190.6% | |
Share capital | Rs m | 314 | 81 | 388.9% | |
"Free" reserves | Rs m | 55,961 | 1,894 | 2,954.3% | |
Net worth | Rs m | 56,275 | 1,975 | 2,849.6% | |
Long term debt | Rs m | 2,456 | 0 | - | |
Total assets | Rs m | 95,706 | 2,093 | 4,572.0% | |
Interest coverage | x | 0 | 5.6 | -0.3% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.3 | 0 | 1,115.9% | |
Return on assets | % | -0.3 | 3.2 | -11.1% | |
Return on equity | % | -2.7 | 2.6 | -104.0% | |
Return on capital | % | 0 | 4.0 | -1.0% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 3,187 | 0 | - | |
Fx outflow | Rs m | 327 | 0 | - | |
Net fx | Rs m | 2,860 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 3,840 | 59 | 6,454.4% | |
From Investments | Rs m | -2,295 | -160 | 1,436.4% | |
From Financial Activity | Rs m | -222 | 101 | -220.2% | |
Net Cashflow | Rs m | 1,323 | 0 | 472,500.0% |
Indian Promoters | % | 59.3 | 35.5 | 167.1% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 9.4 | 0.1 | 7,223.1% | |
FIIs | % | 8.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 40.7 | 64.5 | 63.1% | |
Shareholders | 55,280 | 22,589 | 244.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare DISHMAN CARBOGEN AMCIS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | DISHMAN CARBOGEN AMCIS | Zandu Realty | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -3.22% | 2.63% | -0.28% |
1-Month | 30.28% | -6.21% | -0.94% |
1-Year | 37.27% | 48.78% | 45.03% |
3-Year CAGR | 0.11% | 7.79% | 19.07% |
5-Year CAGR | 11.11% | 12.55% | 25.81% |
* Compound Annual Growth Rate
Here are more details on the DISHMAN CARBOGEN AMCIS share price and the Zandu Realty share price.
Moving on to shareholding structures...
The promoters of DISHMAN CARBOGEN AMCIS hold a 59.3% stake in the company. In case of Zandu Realty the stake stands at 35.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of DISHMAN CARBOGEN AMCIS and the shareholding pattern of Zandu Realty.
Finally, a word on dividends...
In the most recent financial year, DISHMAN CARBOGEN AMCIS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
Zandu Realty paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of DISHMAN CARBOGEN AMCIS, and the dividend history of Zandu Realty.
For a sector overview, read our pharmaceuticals sector report.
After opening the day marginally lower, Indian benchmark indices reversed the trend as the session progressed and ended the day higher.